Medicare Part D coverage · baclofen · RxCUI 2593376
baclofen 5 MG/ML Oral Suspension
Per the CMS 2026 Part D formulary file, baclofen 5 MG/ML Oral Suspension is covered by 121 Medicare Part D plans (2.4% of enrollable products), averaging Tier 3.7, with prior authorization required on 0% of covering formularies.
- 2.4%
- Plan coverage
- 121
- Plans covering
- T3.7
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for baclofen 5 MG/ML Oral Suspension
Per the CMS 2026 Part D formulary file, baclofen 5 MG/ML Oral Suspension (RxNorm concept RXCUI 2593376, generic name baclofen) appears on 6 distinct formulary files spanning 121 Medicare Part D plan offerings - 2.4% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 3.7.
Real-world access to baclofen 5 MG/ML Oral Suspension depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,303,677 Part D beneficiaries filled baclofen 5 MG/ML Oral Suspension in 2023, with total plan-and-beneficiary spending of $115,342,005 and an average per-beneficiary annual cost of $88.47. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry baclofen 5 MG/ML Oral Suspension today.
Coverage Details
- Formularies covering
- 6
- Plans covering
- 121
- Coverage rate
- 2.4%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 1,303,677
- Total spending
- $115,342,005
- Avg per beneficiary
- $88.47
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering baclofen 5 MG/ML Oral Suspension
100 Medicare Advantage plans with Part D drug coverage include this drug.
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is baclofen 5 MG/ML Oral Suspension covered by Medicare Part D?
Yes, baclofen 5 MG/ML Oral Suspension is covered by 121 Medicare Part D plans (2.4% of all Part D formularies).
What tier is baclofen 5 MG/ML Oral Suspension on Medicare Part D plans?
baclofen 5 MG/ML Oral Suspension averages Tier 3.7 across Part D plans, ranging from Tier 1 to Tier 5.
Does baclofen 5 MG/ML Oral Suspension require prior authorization?
0% of Part D formularies require prior authorization for baclofen 5 MG/ML Oral Suspension. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on baclofen 5 MG/ML Oral Suspension?
In 2023, total Medicare Part D spending on baclofen 5 MG/ML Oral Suspension was $115,342,005, covering 1,303,677 beneficiaries. The average spend per beneficiary was $88.47.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- Modified 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet T3.7
- ergotamine tartrate 2 MG Sublingual Tablet [Ergomar] T3.7
- sildenafil 10 MG/ML Oral Suspension T3.7
- somatropin 12 MG Cartridge [Humatrope] T3.7
- nitrofurantoin 10 MG/ML Oral Suspension T3.7
- dalbavancin 500 MG Injection [Dalvance] T3.7